OXiGENE is a biopharmaceutical company whose mission is finding and developing new and improved therapeutics that can deliver significant medical benefits to patients with cancer and sight-threatening eye diseases and conditions.

Wednesday, May 9, 2012
OXiGENE Reports First Quarter 2012 Financial Results

Wednesday, May 2, 2012
OXiGENE Announces First Quarter 2012 Earnings Conference Call and Webcast